NextCell Pharma Stock

NextCell Pharma Net Margin

The Net Profit Margin of NextCell Pharma (NXTCL.ST) as of Aug 1, 2026 is -321.31 %. In the previous year, Net Profit Margin was -393.45 % — a change of -18.33% (higher).

Net Margin

-321.31 %

YoY

-18.33%

Last updated:

Net Profit Margin of NextCell Pharma is 2026 -321.31 % . Net Profit Margin of NextCell Pharma was 2025 -393.45 % . It decreases by -18.33% higher compared to the previous year.

For NextCell Pharma, the net margin of -321.3% is up versus -627.9% a few years ago.

Access this data via the Eulerpool API

NextCell Pharma Stock analysis

What does NextCell Pharma do? NextCell Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NextCell Pharma stock

Net Profit Margin of NextCell Pharma is -321.31 % in 2026.

Access this data via the Eulerpool API

Margins — NextCell Pharma

All Key Metrics — NextCell Pharma